Coronavirus channel feed – Endpoints News

Coronavirus channel feed

Passive vaccination? AstraZeneca spotlights six-month protection with Covid-19 antibody among vulnerable group

4 years ago

Covid-19 roundup: CDC advisory committee to discuss Pfizer/BioNTech boosters for all adults; US buys up $1B in GSK/Vir mAbs

4 years ago

Covid-19 pill could add another $15-25B to Pfizer's already torrid pandemic cash flow — analyst

4 years ago

In wake of PhII flop, Roche walks away from $350M Covid-19 antiviral pact

4 years ago

Another one bites the dust: Novartis, Molecular Partners and their antiviral get the boot from NIH Covid study

4 years ago

Covid-19 roundup: Pfizer licenses its pill to the Medicines Patent Pool; NYC joins states in authorizing boosters for all adults ahead of FDA

4 years ago

BioNTech CEO interview: On boosters, the future of Covid-19, and the plan to make and ship the next vaccine in 3 months

4 years ago

Covid-19 roundup: Adagio plans to submit EUA by Q2 in 2022; HIPRA to enter PhII trials

4 years ago

Moderna disputes NIH claims on Covid-19 vaccine patents, says it offered to make government co-owners

4 years ago

Covid-19 roundup: Moderna notes higher myocarditis risk for young males when compared to Pfizer's vaccine; EMA signs off on Roche, Celltrion mAb treatments

4 years ago

NIH 'not done' fighting Moderna over Covid vaccine patents, director Francis Collins says

4 years ago

Moderna and NIH can't agree on who invented the lifesaving Covid-19 vaccine, and their feud is now public — report

4 years ago

Covid-19 roundup: AstraZeneca launches new virus R&D division; US buys more of Merck's antiviral pill

4 years ago

Covid-19 roundup: Regeneron/Roche antibody combo keeps its punch 8 months in; WaPo: Pfizer expected to seek authorization for boosters for all adults

4 years ago

Covid-19 roundup: Novavax's manufacturing woes nearing an end?; FDA rejects coronavirus drug in NIH trial

4 years ago

Breaking: Pfizer's Covid-19 antiviral reduces hospitalizations by 89%, could prove a formidable foe for Merck's pill

4 years ago

BARDA, Emergent BioSolutions break off $600M Covid-19 vaccine manufacturing deal

4 years ago

SaudiVax and MilliporeSigma team up to manufacture domestic vaccine for the Arabian peninsula

4 years ago

Covid-19 roundup: Moderna's stock plunges after lower sales forecast is revealed; Regeneron sees $804M in Q3 monoclonal antibody sales

4 years ago

Covid-19 roundup: Eli Lilly withdraws mAbs from EMA review

4 years ago

Covid-19 roundup: Pfizer raises 2021 vaccine sales forecast to $36B; Lilly lands $1.3B treatment deal with US government

4 years ago

FDA safety review to hold up Moderna’s Covid-19 vaccine for teens until 2022

4 years ago

FDA clears Pfizer's Covid-19 vaccine for children ages 5-11

4 years ago

Covid-19 roundup: Takeda preps rollout of Novavax shot for next year — report; G20 targets 70% world vaccination rate by mid-2022

4 years ago

First page Previous page 17 18 192021 22 23 Next page Last page